Clinical Trials on Moderate to Severe Plaque Psoriasis in Australia
Total 73 results
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Croma-Pharma GmbHCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
Delenex Therapeutics AGCompletedMild-to-moderate Psoriasis VulgarisAustria, Germany
-
KoBioLabsActive, not recruitingA Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type PsoriasisPsoriatic PlaqueUnited States, Australia
-
Zai Lab (Hong Kong), Ltd.Zai Lab (US) LLCNot yet recruiting
-
Santalis Pharmaceuticals, Inc.ClinDatrix, Inc.; Fremantle DermatologyWithdrawn
-
PfizerCompletedPlaque-type PsoriasisAustralia
-
Azora Therapeutics Australia Pty LtdActive, not recruitingPlaque Psoriasis | Nail PsoriasisAustralia
-
TetraLogic PharmaceuticalsCompleted
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
Medical University of ViennaCompletedPlaque PsoriasisAustria
-
Almirall, S.A.Recruiting
-
Merck KGaA, Darmstadt, GermanyTerminated
-
Almirall, S.A.Harrison Clinical Research; Almirall Hermal GmbHCompletedPlaque PsoriasisAustria, Germany, Netherlands, Poland
-
Maruho Europe LimitedMaruho Co., Ltd.CompletedPlaque PsoriasisGermany, Austria, Bulgaria, Hungary, Lithuania, Poland
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Almirall, S.A.Active, not recruitingPlaque PsoriasisGermany, Austria, Italy, Netherlands
-
Arcutis Biotherapeutics, Inc.CompletedPlaque PsoriasisUnited States, Australia, Bulgaria, Canada
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
ActelionCompleted
-
AbbVieCompletedPlaque PsoriasisUnited States, Australia, Germany, Israel, Italy, Spain, Taiwan, United Kingdom
-
Bausch Health Americas, Inc.TerminatedPlaque PsoriasisUnited States, Belgium, Italy, Hungary, Poland, Australia, France, Greece, Russian Federation, Latvia, Canada
-
Coherus Biosciences, Inc.ShireCompletedPlaque PsoriasisUnited States, Israel, Australia, Germany, South Africa, Poland, Canada
-
Eli Lilly and CompanyCompletedA Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)Plaque PsoriasisGermany, Spain, Belgium, France, Hungary, Austria, Canada, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom
-
PfizerCompletedPsoriasis | Plaque PsoriasisSpain, Taiwan, Germany, Korea, Republic of, Belgium, Greece, Hungary, Argentina, Austria, Czech Republic, Italy, Mexico, Thailand
-
Bristol-Myers SquibbRecruitingPlaque PsoriasisAustralia, Mexico, Canada, United Kingdom, France, Argentina, Japan, Poland, Spain, Korea, Republic of, Brazil, Germany, Romania
-
AmgenCompletedPlaque PsoriasisSpain, United States, Canada, Germany, Denmark, France, Italy, Switzerland, Austria
-
LEO PharmaTerminatedPsoriasis | Plaque Psoriasis | Psoriasis VulgarisBelgium, Germany, Italy, Spain, Denmark, Austria, France, Greece, Switzerland, United Kingdom, Netherlands, Sweden
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Austria, Canada, Poland
-
Eli Lilly and CompanyCompletedPlaque PsoriasisArgentina, Puerto Rico, United States, Australia, Taiwan, Japan, Hungary, Korea, Republic of, Mexico, Germany, Poland, Romania, Czechia, Canada
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisGermany, United States, Hungary, Italy, Turkey, Korea, Republic of, United Kingdom, China, Taiwan, Poland, Canada, France, Japan, Australia, Spain, Argentina
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...